A novel proline-rich cathelicidin from the alpaca vicugna pacos with potency to combat antibiotic-resistant bacteria: mechanism of action and the functional role of the c-terminal region

HIGHLIGHTS

• who: Pavel V. Panteleev and collaborators from the The following reference strains were utilized: Escherichia coli , (DE3), Ecoli DH B, E. coli ML-35p, E. coli ATCC, Pseudomonas aeruginosa ATCC, P. aeruginosa PAO1, Staphylococcus aureus ATCC P, S. aureus ATCC, Bacillus subtilis, B. licheniformis VKM, Mycobacterium phlei Ac-1291. Strain E. coli , and its knockout variants u2206sbmA, u2206mdtM, u2206ompF from the KEIO collection [25] were kindly provided by Dr. Ilya A. Osterman. The clinical isolates were collected and provided by Sechenov First Moscow State Medical University hospital and Solixant LLC (Moscow, Russia). The detailed characteristics of utilized . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.